Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo‐controlled trial
Yiming Mu(Chinese PLA General Hospital), Changyu Pan(University of Auckland), L. Pauer(Pfizer (United States)), Ningxiu Shang(Pfizer (China)), Kangning Chen(Fudan University), Yu Liu(Shenzhen University Health Science Center), Xiao-Min Liu(Harbin Medical University), Xiaofeng Lv(Zhejiang University of Technology), Xiangjin Xu(Nanjing General Hospital of Nanjing Military Command), Dongsheng Fan(King University), Ruoyong Yang(Pfizer (United States)), Quanmin Li(Chinese PLA General Hospital)
Cited by 34
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554